Get the Stockscreener App
2.84
1.39%
-0.04
After Hours:
2.84
Rocket Pharmaceuticals Inc stock is traded at $2.84, with a volume of 2.87M.
It is down -1.39% in the last 24 hours and down -29.00% over the past month.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
See More
Previous Close:
$2.88
Open:
$2.93
24h Volume:
2.87M
Relative Volume:
0.79
Market Cap:
$306.45M
Revenue:
-
Net Income/Loss:
$-258.08M
P/E Ratio:
-1.0327
EPS:
-2.75
Net Cash Flow:
$-202.32M
1W Performance:
-10.41%
1M Performance:
-29.00%
6M Performance:
-58.54%
1Y Performance:
-78.22%
1-Day Range:
$2.815
$3.07
1-Week Range:
$2.815
$3.2491
52-Week Range:
$2.19
$15.01
Rocket Pharmaceuticals Inc Stock (RCKT) Company Profile
Name
Rocket Pharmaceuticals Inc
Sector
Industry
Phone
646-440-9100
Address
350 FIFTH AVENUE, NEW YORK, NY
Compare RCKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCKT
Rocket Pharmaceuticals Inc
|
2.84 | 311.68M | 0 | -258.08M | -202.32M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rocket Pharmaceuticals Inc Stock (RCKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-18-25 | Downgrade | JP Morgan | Neutral → Underweight |
| Aug-20-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-25-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-30-25 | Downgrade | Evercore ISI | Outperform → In-line |
| May-28-25 | Downgrade | Goldman | Neutral → Sell |
| May-28-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-28-25 | Downgrade | Jefferies | Buy → Hold |
| May-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| May-28-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-27-25 | Downgrade | Needham | Buy → Hold |
| May-27-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-12-25 | Initiated | BMO Capital Markets | Outperform |
| Dec-30-24 | Initiated | Wedbush | Outperform |
| Dec-18-24 | Initiated | Jefferies | Buy |
| Oct-16-24 | Initiated | Scotiabank | Sector Outperform |
| Apr-02-24 | Initiated | Goldman | Neutral |
| Oct-24-23 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-23 | Initiated | Morgan Stanley | Overweight |
| Nov-08-22 | Initiated | Canaccord Genuity | Buy |
| Nov-01-22 | Initiated | BTIG Research | Buy |
| Jul-08-22 | Initiated | Raymond James | Outperform |
| Oct-20-21 | Resumed | Cowen | Outperform |
| Mar-02-21 | Initiated | Stifel | Buy |
| Feb-18-21 | Initiated | Needham | Buy |
| Dec-16-20 | Initiated | UBS | Buy |
| Dec-08-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Jul-02-20 | Initiated | JP Morgan | Overweight |
| Jun-25-20 | Resumed | BofA/Merrill | Buy |
| Jun-01-20 | Resumed | Oppenheimer | Outperform |
| Nov-06-19 | Initiated | Chardan Capital Markets | Buy |
| Sep-26-19 | Initiated | Piper Jaffray | Overweight |
| Apr-23-19 | Initiated | Robert W. Baird | Outperform |
| Mar-15-19 | Initiated | BofA/Merrill | Buy |
| Feb-05-19 | Initiated | Oppenheimer | Outperform |
| Sep-13-18 | Initiated | Ladenburg Thalmann | Buy |
| Jul-10-18 | Initiated | William Blair | Outperform |
View All
Rocket Pharmaceuticals Inc Stock (RCKT) Latest News
How Rocket Pharmaceuticals Inc. (9IP1) stock compares with top peersTrend Reversal & Stepwise Trade Execution Plans - newser.com
How Rocket Pharmaceuticals Inc. stock reacts to inflationary pressuresWall Street Watch & Safe Capital Growth Tips - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock trades after rate cutsJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
Published on: 2025-11-20 03:46:18 - newser.com
Is Rocket Pharmaceuticals Inc. stock oversold or undervalued2025 Risk Factors & Intraday High Probability Alerts - newser.com
Using data models to predict Rocket Pharmaceuticals Inc. Equity Warrant stock movementJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock sustain revenue momentumTrade Volume Summary & Accurate Trade Setup Notifications - newser.com
What dividend safety rating applies to Rocket Pharmaceuticals Inc. (9IP1) stock2025 AllTime Highs & Technical Analysis for Trade Confirmation - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock undervalued after correctionWeekly Volume Report & Free Reliable Trade Execution Plans - newser.com
Why Rocket Pharmaceuticals Inc. (9IP1) stock could be next leader2025 Short Interest & Low Drawdown Investment Strategies - newser.com
Can Rocket Pharmaceuticals Inc. (9IP1) stock retain market dominanceWeekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
Rocket Pharmaceuticals Inc. recovery potential after sell off2025 Institutional Moves & Weekly Watchlist for Hot Stocks - newser.com
How Rocket Pharmaceuticals Inc. stock performs after earningsBuy Signal & Real-Time Volume Surge Alerts - newser.com
Will Rocket Pharmaceuticals Inc. (9IP1) stock see insider accumulationMarket Risk Analysis & Smart Allocation Stock Reports - newser.com
Why Rocket Pharmaceuticals Inc. stock is considered a top pick2025 Performance Recap & AI Driven Stock Reports - newser.com
How Rocket Pharmaceuticals Inc. (9IP1) stock correlates with oil markets2025 Short Interest & High Accuracy Trade Signal Alerts - newser.com
Heatmap analysis for Rocket Pharmaceuticals Inc. Equity Warrant and competitors2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com
Is Rocket Pharmaceuticals Inc. (9IP1) stock good for wealth creation2025 Top Decliners & Technical Entry and Exit Alerts - newser.com
Will Rocket Pharmaceuticals Inc. Equity Warrant stock recover after recent drop2025 Bull vs Bear & Precise Swing Trade Entry Alerts - newser.com
What is the fair value of Rocket Pharmaceuticals Inc. Equity Warrant stock nowJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
How Rocket Pharmaceuticals Inc. Equity Warrant stock compares to industry benchmarks2025 Breakouts & Breakdowns & Low Risk Investment Opportunities - newser.com
How institutional ownership impacts Rocket Pharmaceuticals Inc. Equity Warrant stockWeekly Trend Report & Breakout Confirmation Alerts - newser.com
Long term hold vs stop loss in Rocket Pharmaceuticals Inc.Portfolio Performance Summary & Risk Controlled Swing Alerts - newser.com
Is Rocket Pharmaceuticals Inc. stock entering bullish territoryQuarterly Market Review & Weekly Top Gainers Trade List - newser.com
Is it time to cut losses on Rocket Pharmaceuticals Inc. Equity Warrant2025 Year in Review & Weekly Top Gainers Alerts - newser.com
Rocket Pharmaceuticals Inc Stock (RCKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.67%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):